{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:46:55Z","timestamp":1773211615618,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.pharep.2016.07.006","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T12:49:58Z","timestamp":1469278198000},"page":"1214-1220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effect of baclofen in mouse forced swimming test"],"prefix":"10.1007","volume":"68","author":[{"given":"Seyedeh Khadijeh","family":"Nazari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Nikoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sattar","family":"Ostadhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra Hadi","family":"Chegini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrbanoo","family":"Oryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Bakhtiarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"3","key":"10.1016\/j.pharep.2016.07.006_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1590\/1516-4446-2013-1294","article-title":"Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis","volume":"36","author":"Silva","year":"2014","journal-title":"Rev Bras Psiquiatr"},{"issue":"12","key":"10.1016\/j.pharep.2016.07.006_bib0010","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1176\/ajp.2006.163.12.2141","article-title":"Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991 and 1992 and 2001\u20132002","volume":"163","author":"Compton","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.pharep.2016.07.006_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0193-953X(18)30164-3","article-title":"Treatment resistance in unipolar depression and other disorders: diagnostic concerns and treatment possibilities","volume":"16","author":"Nelsen","year":"1993","journal-title":"Psychiatr Clin North Am"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Part 1","key":"10.1016\/j.pharep.2016.07.006_bib0025","first-page":"1","article-title":"Treatment-resistant depression","volume":"10","author":"Kay","year":"2006","journal-title":"Psychiatry"},{"issue":"Suppl 6","key":"10.1016\/j.pharep.2016.07.006_bib0030","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.pharep.2016.07.006_bib0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1358\/dot.2005.41.11.904728","article-title":"GABAergic hypotheses of anxiety and depression: focus on GABAB receptors","volume":"41","author":"Pilc","year":"2005","journal-title":"Drugs Today (Barc)"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2004.05.053","article-title":"Immunocytochemical localization of GABA B R1 receptor subunits in the basolateral amygdala","volume":"1018","author":"McDonald","year":"2004","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","article-title":"Don\u2019t worry \u2018B\u2019happy!: a role for GABA B receptors in anxiety and depression","volume":"26","author":"Cryan","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.pharep.2016.07.006_bib0050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001362","article-title":"GABAergic dysfunction in mood disorders","volume":"8","author":"Brambilla","year":"2003","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.pharep.2016.07.006_bib0055","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.npp.1300413","article-title":"Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety-and antidepressant-like behavior","volume":"29","author":"Mombereau","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharep.2016.07.006_bib0060","first-page":"645","article-title":"Effects of GABAB receptor ligands in animal tests of depression and anxiety","volume":"59","author":"Frankowska","year":"2007","journal-title":"Pharmacol Rep"},{"issue":"26","key":"10.1016\/j.pharep.2016.07.006_bib0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2015.12.006","article-title":"The involvement of NMDA receptor\/NO\/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test","volume":"612","author":"Khan","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2016.07.006_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2016.03.034","article-title":"Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test","volume":"780","author":"Haj-Mirzaian","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2016.07.006_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and l-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"Ostadhadi","year":"2016","journal-title":"Brain Res Bull"},{"issue":"4","key":"10.1016\/j.pharep.2016.07.006_bib0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00210-015-1203-5","article-title":"Involvement of NO\/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test","volume":"389","author":"Ostadhadi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6474","key":"10.1016\/j.pharep.2016.07.006_bib0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/368850a0","article-title":"Nitric-oxide directly activates calcium-dependent potassium channels in vascular smooth-muscle cells","volume":"368","author":"Bolotina","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0090","first-page":"H423","article-title":"Role of ATP-sensitive K+ channels in cGMP-mediated pial artery vasodilation","volume":"270","author":"Armstead","year":"1996","journal-title":"Am J Physiol."},{"issue":"3","key":"10.1016\/j.pharep.2016.07.006_bib0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-5793(97)01144-7","article-title":"Nitric oxide directly activates calcium-activated potassium channels from rat brain reconstituted into planar lipid bilayer","volume":"415","author":"Shin","year":"1997","journal-title":"FEBS lett"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0100","first-page":"97","article-title":"Nitric oxide directly activates large conductance Ca 2+-activated K+ channels (rSlo)","volume":"12","author":"Jeong","year":"2001","journal-title":"Mol Cells"},{"issue":"23","key":"10.1016\/j.pharep.2016.07.006_bib0105","doi-asserted-by":"crossref","first-page":"9360","DOI":"10.1073\/pnas.85.23.9360","article-title":"Guanosine 5'-monophosphate modulates gating of high-conductance Ca2+-activated K+ channels in vascular smooth muscle cells","volume":"85","author":"Williams","year":"1988","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-3565(25)23048-8","article-title":"Effects of nitroglycerin on ATP-induced Ca (++)-mobilization, Ca (++)-activated K channels and contraction of cultured smooth muscle cells of porcine coronary artery","volume":"256","author":"Fujino","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","article-title":"Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway","volume":"165","author":"Kaster","year":"2005","journal-title":"Behav Brain Res"},{"issue":"7","key":"10.1016\/j.pharep.2016.07.006_bib0120","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.bjp.0702467","article-title":"Effect of potassium channel modulators in mouse forced swimming test","volume":"126","author":"Galeotti","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2016.07.006_bib0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pbb.2003.12.024","article-title":"Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation","volume":"77","author":"Inan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"10.1016\/j.pharep.2016.07.006_bib0130","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1300484","article-title":"Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs","volume":"29","author":"Kobayashi","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharep.2016.07.006_bib0135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.pnpbp.2006.12.018","article-title":"The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test","volume":"31","author":"Kaster","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2004.05.065","article-title":"Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons","volume":"1018","author":"Choi","year":"2004","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(02)02239-2","article-title":"Differential blockade of neuronal voltage-gated Na+ and K+ channels by antidepressant drugs","volume":"452","author":"Nicholson","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2016.07.006_bib0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1254\/jphs.FP0060708","article-title":"Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine","volume":"102","author":"Kobayashi","year":"2006","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02245627","article-title":"The additive effects of quinine on antidepressant drugs in the forced swimming test in mice","volume":"121","author":"Guo","year":"1995","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pharep.2016.07.006_bib0160","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0091-3057(95)02226-0","article-title":"Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade","volume":"54","author":"Guo","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2016.07.006_bib0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.03.053","article-title":"Opioid\/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test","volume":"735","author":"Haj-Mirzaian","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1440-1681.12518","article-title":"Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice","volume":"43","author":"Ostadhadi","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharep.2016.07.006_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.11.009","article-title":"Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test","volume":"141","author":"Kordjazy","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"issue":"19","key":"10.1016\/j.pharep.2016.07.006_bib0180","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s00213-015-4004-0","article-title":"Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests","volume":"232","author":"Haj-Mirzaian","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2016.07.006_bib0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejphar.2015.06.030","article-title":"Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice","volume":"762","author":"Kordjazy","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2016.07.006_bib0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1139\/cjpp-2015-0429","article-title":"Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-d-aspartate and opioid receptors","volume":"94","author":"Haj-Mirzaian","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0195","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2016.07.006_bib0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biopha.2016.04.026","article-title":"Antidepressant effect of pramipexole in mice forced swimming test: a cross talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway","volume":"81","author":"Ostadhadi","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2016.07.006_bib0205","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2016.05.035","article-title":"Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test","volume":"82","author":"Ostadhadi","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.pharep.2016.07.006_bib0210","first-page":"758","article-title":"Antidepressant-like effects of baclofen and LY367385 in the forced swim test in rats","volume":"58","author":"Car","year":"2005","journal-title":"Pharmacol Rep"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-6147(99)01413-3","article-title":"The \u2018ABC\u2019of GABA receptors","volume":"21","author":"Bormann","year":"2000","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.pharep.2016.07.006_bib0230","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0042-6989(97)00277-0","article-title":"Molecular composition of GABAC receptors","volume":"38","author":"Enz","year":"1998","journal-title":"Vis Res"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/pr.54.2.247","article-title":"International Union of Pharmacology. XXXIII. Mammalian \u03b3-aminobutyric acidB receptors: structure and function","volume":"54","author":"Bowery","year":"2002","journal-title":"Pharmacol Rev."},{"issue":"3","key":"10.1016\/j.pharep.2016.07.006_bib0240","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0896-6273(00)80381-5","article-title":"G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons","volume":"19","author":"L\u00fcscher","year":"1997","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"02","key":"10.1016\/j.pharep.2016.07.006_bib0250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1461145704004080","article-title":"Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders","volume":"7","author":"Morilak","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2016.07.006_bib0255","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.pharep.2016.07.006_bib0260","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","article-title":"Reduced cortical \u03b3-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy","volume":"56","author":"Sanacora","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevNeurobiol.v14.i1.20","article-title":"Impairment of GABAergic transmission in depression: new insights from neuroimaging studies","volume":"14","author":"Sanacora","year":"2000","journal-title":"Crit Rev Neurobiol"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.2010.01004.x","article-title":"The GABAB receptor as a target for antidepressant drug action","volume":"162","author":"Ghose","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-197408010-00001","article-title":"Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity","volume":"8","author":"Brogden","year":"1974","journal-title":"Drugs"},{"key":"10.1016\/j.pharep.2016.07.006_bib0280","first-page":"18","article-title":"Effect of baclofen, a GABAB-agonist, on forced swimming-induced immobility in mice","volume":"307","author":"Aley","year":"1989","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"5","key":"10.1016\/j.pharep.2016.07.006_bib0285","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0290","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.104.073536","article-title":"GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent","volume":"312","author":"Slattery","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2016.07.006_bib0295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1054-3589(10)58016-5","article-title":"GABA B receptors and depression: current status","volume":"58","author":"Cryan","year":"2010","journal-title":"Adv Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(95)01273-7","article-title":"Involvement of GABA B receptor systems in action of antidepressants: baclofen but not bicuculline attenuates the effects of antidepressants on the forced swim test in rats","volume":"709","author":"Nakagawa","year":"1996","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0896-6273(93)90308-E","article-title":"Local and diffuse synaptic actions of GABA in the hippocampus","volume":"10","author":"Isaacson","year":"1993","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.pharep.2016.07.006_bib0310","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0028-3908(00)00204-5","article-title":"Both GABA B receptor agonist and antagonists decreased brain stimulation reward in the rat","volume":"40","author":"Macey","year":"2001","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0315","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2007.07.048","article-title":"Effects of GABA B receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination","volume":"574","author":"Filip","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2016.07.006_bib0320","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2007.05.069","article-title":"Effects of GABA B receptor agents on cocaine priming, discrete contextual cue and food induced relapses","volume":"571","author":"Filip","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0091-3057(01)00518-4","article-title":"GABA A but not GABA B receptor stimulation induces antianxiety profile in rats","volume":"69","author":"Zarrindast","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pharep.2016.07.006_bib0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0163-7258(02)00201-2","article-title":"K+ channels as therapeutic drug targets","volume":"94","author":"Wickenden","year":"2002","journal-title":"\u200ePharmacol Ther"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:37Z","timestamp":1752611797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.07.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1734114016300937"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.07.006","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effect of baclofen in mouse forced swimming test","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}